Personalized mRNA Neoantigen Vaccines in Cancer: Linking Precision Antigen Selection, Immune Remodeling, and Checkpoint Blockade
Turan Demircan, Berna Yıldırım, Halil İbrahim Ünsal, Ayhan Bilir · 2026
Read Personalized mRNA Neoantigen Vaccines in Cancer: Linking Precision Antigen Selection, Immune Remodeling, and Checkpoint Blockade by Turan Demircan, Berna Yıldırım, Halil İbrahim Ünsal, Ayhan Bilir (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13607411.txt.
Description
Turan Demircan and three co-authors review cancer vaccines made to order for each patient, in a 2026 paper. These vaccines use mRNA, a short-lived copy of a gene, built from the odd proteins found only in that patient's tumor. The goal is to teach the immune system to attack the cancer.
The review covers three linked steps. First, labs must pick the right tumor targets and build the vaccine well. Next, the vaccine must wake up strong killer cells that keep working inside the tumor. Last, these vaccines may pair with drugs that release the brakes on immune cells. The authors review trial results in skin, lung, and pancreatic cancer, and list what may set apart patients who gain lasting benefit.
Catalog record
| CREATOR | Turan Demircan, Berna Yıldırım, Halil İbrahim Ünsal, Ayhan Bilir |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |